Heparin-induced thrombocytopenia (HIT) is a rare complication that has been reported to occur in 0.36% of trauma patients and is caused by antibody formation to complexes between heparin and platelet-factor 4 (PF4), leading to platelet activation and subsequent thrombosis.
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1,2 An earlier report demonstrated that PF4 can bind to bacteria, inducing an autoimmune response similar to the major antigen in HIT. 3 We hypothesized that trauma patients with HIT have a higher incidence of bacterial infection during their hospitalization compared with patients without HIT. In addition, we provide a descriptive analysis of HIT in trauma patients.
Methods | This study was approved by the institutional review board of the University of California, Irvine. The need for informed consent was waived by the institutional review board of the University of California, Irvine. We queried the National Trauma Data Bank from 2008 through 2015 to identify patients with HIT using the International Classification of Diseases, Ninth Revision (289.84) . Because of the observed imbalance in the sample size, we used a 1:2 ratio propensity score model to match patients with HIT to those without HIT using demographic and injury profile parameters (Table) . Our analysis included only cases that were within 0.001 of the estimated logit. 4 If a patient with HIT did not have a close match, they were excluded. A Student t test was used to compare continuous variables, and the χ 2 test was used to compare categorical variables for bivariate analysis. The primary outcomes were incidence of bacterial infection, urinary tract infection, and pneumonia. Bacterial infection was defined as gastrointestinal tract bacterial infection or bacteremia. Analysis of outcomes was performed using a logistic regression model and reported with odds ratios (ORs) and 95% CIs; the statistical significance level was set at a 2-sided P < .05. certain bacteria can induce anti-PF4/heparin antibodies in a mouse model after PF4 binds to bacteria. Our study demonstrates that this may also occur in trauma patients, because patients with HIT were more likely to have a bacterial infection, urinary tract infection, or pneumonia during their hospitalization than were patients without HIT. Limitations to our study include those inherent to retrospective databases leading to reporting bias. As such, the true incidence of HIT may be several-fold higher than that reported here. The temporal relation of HIT and bacterial infection is not defined in the National Trauma Data Bank. It is therefore not possible to know which patients developed HIT after a bacterial infection, thus limiting us from drawing final conclusions.
Conclusions | The incidence of HIT among trauma patients may be lower than previously reported. Our study found an association between HIT and bacterial infection in trauma patients. A multicenter effort may prospectively validate our findings and determine whether the presence of bacterial infection can be used as an adjunct to current risk assessment tools for HIT. 
